The price of Neuronetics Inc. (NASDAQ:STIM) shares last traded on Wall Street fell -10.93% to $3.75.
Based on available information, 4 analysts follow Neuronetics Inc. (NASDAQ:STIM). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $12.00 and a low of $7.00, we find $7.00. Given the previous closing price of $4.21, this indicates a potential upside of 66.27 percent. STIM stock price is now -36.62% away from the 50-day moving average and -14.60% away from the 200-day moving average. The market capitalization of the company currently stands at $101.10M.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Among analysts, 1 rate the stock a hold while 3 rate it a buy. Brokers who have rated the stock have averaged $8.67 as their price target over the next twelve months.
, while ‘William Blair’ rates the stock as ‘Outperform’.
In other news, MACAN WILLIAM ANDREW, EVP, GC, CCO and CS sold 11,044 shares of the company’s stock on Feb 16. The stock was sold for $65,270 at an average price of $5.91. Upon completion of the transaction, the EVP, GC, CCO and CS now directly owns 400,539 shares in the company, valued at $1.5 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 15, CFO Furlong Stephen sold 13,148 shares of the business’s stock. A total of $77,573 was realized by selling the stock at an average price of $5.90. This leaves the insider owning 442,134 shares of the company worth $1.66 million. Insiders disposed of 681,569 shares of company stock worth roughly $2.56 million over the past 1 year. A total of 6.20% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in STIM stock. A new stake in Neuronetics Inc. shares was purchased by EAM INVESTORS, LLC during the first quarter worth $1,135,000. HILLSDALE INVESTMENT MANAGEMENT INC. invested $353,000 in shares of STIM during the first quarter. In the first quarter, SUSQUEHANNA INTERNATIONAL GROUP, LLP acquired a new stake in Neuronetics Inc. valued at approximately $296,000. JANE STREET GROUP, LLC acquired a new stake in STIM for approximately $212,000. XTX TOPCO LTD purchased a new stake in STIM valued at around $168,000 in the second quarter.
During the past 12 months, Neuronetics Inc. has had a low of $1.98 and a high of $6.95. As of last week, the company has a debt-to-equity ratio of 0.57, a current ratio of 4.00, and a quick ratio of 3.70. The fifty day moving average price for STIM is $5.9164 and a two-hundred day moving average price translates $4.3913 for the stock.
The latest earnings results from Neuronetics Inc. (NASDAQ: STIM) was released for Sep, 2022. The net profit margin was -58.90% and return on equity was -49.80% for STIM. The company reported revenue of $18.2 million for the quarter, compared to $15.02 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 21.14 percent.
Leave a Reply